Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock

NCT06746753 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock

Interventions

DRUG: Angiotensin II
DRUG: Norepinephrine

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]